These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6419681)

  • 1. Arachidonic acid and prostanoids in suction blister fluid from psoriatic lesions and unaffected skin.
    Hensby C; Juhlin L; Civier A; Berne B; Michaëlsson G; Vahlqvist C
    Arch Dermatol Res; 1983; 275(5):350-2. PubMed ID: 6419681
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
    Ruzicka T; Simmet T; Peskar BA; Ring J
    J Invest Dermatol; 1986 Feb; 86(2):105-8. PubMed ID: 3018086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolites of arachidonic acid in psoriasis.
    Wilkinson DI
    Cutis; 1984 Apr; 33(4):353, 358. PubMed ID: 6426865
    [No Abstract]   [Full Text] [Related]  

  • 4. The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin.
    Barr RM; Wong E; Mallet AI; Olins LA; Greaves MW
    Prostaglandins; 1984 Jul; 28(1):57-65. PubMed ID: 6435188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of combined ultraviolet A irradiation and oral psoralens (PUVA) on skin arachidonic acid and prostaglandin concentrations in psoriasis [proceedings].
    Greaves MW; Hensby CN; Plummer NA; Warin AP
    Br J Pharmacol; 1978 Jun; 63(2):372P. PubMed ID: 667452
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of arachidonic acid metabolites in the skin].
    Brus R; Rzempołuch E; Wylezoł M
    Przegl Dermatol; 1990; 77(5):313-7. PubMed ID: 2270293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses.
    Voorhees JJ
    Arch Dermatol; 1983 Jul; 119(7):541-7. PubMed ID: 6305285
    [No Abstract]   [Full Text] [Related]  

  • 8. Arachidonic acid transformations in normal and psoriatic skin.
    Hammarström S; Lindgren JA; Marcelo C; Duell EA; Anderson TF; Voorhees JJ
    J Invest Dermatol; 1979 Aug; 73(2):180-3. PubMed ID: 572390
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
    Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of hyaluronate in suction blister fluid from active psoriatic lesions.
    Lundin A; Engström-Laurent A; Michaëlsson G; Tengblad A
    Br J Dermatol; 1987 Mar; 116(3):335-40. PubMed ID: 3567072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of prostaglandins by psoriatic skin.
    Kassis V; Weismann K; Heiligstädt H; Sondergaard J
    Arch Dermatol Res (1975); 1977 Sep; 259(3):207-12. PubMed ID: 199118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
    Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI
    Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins E2, F2alpha and arachidonic acid levels in irradiated and unirradiated skin of psoriatic patients receiving PUVA treatment.
    Plummer NA; Hensby CN; Warin AP; Camp RD; Greaves MW
    Clin Exp Dermatol; 1978 Dec; 3(4):367-9. PubMed ID: 737880
    [No Abstract]   [Full Text] [Related]  

  • 14. [Leukotrienes and monohydroxy fatty acids: controversial role in the pathogenesis of psoriasis].
    Ruzicka T
    Hautarzt; 1985 May; 36(5):255-8. PubMed ID: 2989218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins and skin.
    Hensby CN; Kingston WP; Greaves MW
    Clin Exp Dermatol; 1976 Dec; 1(4):385-90. PubMed ID: 793746
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of vasoactive agents on prostanoids in suction blister fluid.
    Juhlin L; Civier A; Hensby C; Shroot S
    Acta Derm Venereol; 1983; 63(6):536-8. PubMed ID: 6198845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.
    Kragballe K; Duell EA; Voorhees JJ
    Arch Dermatol; 1986 Aug; 122(8):877-80. PubMed ID: 3090943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical, pharmacological and therapeutic aspects of skin metabolism of arachidonic acid].
    Bouclier M; Hensby CN
    Ann Dermatol Venereol; 1986; 113(12):1289-93. PubMed ID: 3105409
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis.
    Barr RM; Wong E; Cunningham FM; Mallet AI; Greaves MW
    Arch Dermatol Res; 1989; 280(8):474-6. PubMed ID: 2537608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotides, prostaglandins and polyamines in psoriasis.
    Marcelo CL; Voorhees JJ
    Pharmacol Ther; 1980; 9(3):297-310. PubMed ID: 6251486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.